COURTNEY SCHWANKE: Open Payments
NPI 1225430895 · EL DORADO, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,596 in 137 payments from 24 companies in 2025. Trend: 2023 $254 · 2024 $2,611 · 2025 $2,596
Food & beverage: $2,596
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $313 |
| ABBVIE INC. | 18 | $309 |
| AstraZeneca Pharmaceuticals LP | 11 | $281 |
| Amgen Inc. | 16 | $226 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $196 |
| Otsuka America Pharmaceutical, Inc. | 11 | $187 |
| PFIZER INC. | 11 | $171 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $155 |
| Dexcom, Inc. | 2 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $141 |
Products named: QULIPTA, Kerendia, REXULTI, Wegovy, NURTEC ODT, XIFAXAN, EVENITY, CAPLYTA.
Industry payments across KS — which companies pay providers there.
